What's happening
The bill requires all New York schools to provide public access to epinephrine auto-injectors, properly maintain them, and post their locations.
Why it matters
Expanding access to emergency allergy treatment. By requiring all types of schools (public, charter, non-public, and vocational) to act as "public access epinephrine auto-injector device providers," the bill significantly increases the chances that life-saving allergy medication will be available wherever children are present.
Mandated maintenance and oversight. The law obligates schools to maintain and regularly test their epinephrine auto-injectors according to manufacturer and government standards, aiming to reduce the risk of device failure during emergencies.
Improved emergency response transparency. Schools must notify local emergency medical councils about the presence and location of these devices and clearly post signs at building entrances, making it easier for staff, students, and first responders to quickly find epinephrine in a crisis.
Potential liability and training considerations. While the bill enhances safety, it may also require schools to dedicate resources to compliance, training, and record-keeping—potentially impacting budgets and operational procedures.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
School districts, BOCES and county vocational education and extension boards
The bill would designate them as public access epinephrine auto-injector device providers, subject to maintenance, testing, notification and signage requirements.
Charter and nonpublic elementary and secondary schools
They would also be covered by the provider designation and would have to post a notice at the main entrance identifying where devices are stored.
Regional councils
Providers would have to notify them of the existence, location and type of epinephrine auto-injector devices they possess.
Headline styles
EpiPens Available in Schools
Plain English, a few words. Used as the page title.
Sponsors
History
- Print number 4909a
- Amend and recommit to education
- Referred to education
- Referred to education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Epinephrine in All School Buildings
In Assembly Committee · Education · Sponsor Iwen Chu
Full text
2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
4909--A
2023-2024 Regular Sessions
IN ASSEMBLY
February 24, 2023
Introduced by M. of A. SAYEGH, BURDICK, BENDETT -- read once and referred to the Committee on Education -- recommitted to the Committee on Education in accordance with Assembly Rule 3, sec. 2 -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee
AN ACT to amend the education law and the public health law, in relation to providing public access to epinephrine auto-injector devices at schools
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Section 921-a of the education law is amended by adding a new subdivision 4 to read as follows:
4. School districts, boards of cooperative educational services, county vocational education and extension boards, charter schools, and nonpublic elementary and secondary schools in this state shall be deemed "public access epinephrine auto-injector device providers" as defined in paragraph (d) of subdivision one of section three thousand-c of the public health law and shall be subject to the requirements and limitations of such section.
§ 2. Subdivision 1 of section 3000-c of the public health law is amended by adding a new paragraph (d) to read as follows:
(d) "Public access epinephrine auto-injector device provider" means a person, firm, organization or other entity possessing or operating an epinephrine auto-injector device pursuant to this section.
§ 3. Subdivision 2 of section 3000-c of the public health law is amended by adding a new paragraph (g) to read as follows:
(g) A public access epinephrine auto-injector device provider shall:
(i) cause an epinephrine auto-injector device to be maintained and tested according to applicable standards of the manufacturer and any appropriate government agency.
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD08722-03-4
(ii) notify the regional council of the existence, location and type of any epinephrine auto-injector device it possesses.
(iii) post a sign or notice at the main entrance to the facility or building in which the epinephrine auto-injector device is stored, indicating the location where any such epinephrine auto-injector device is stored or maintained in such building or facility on a regular basis.
§ 4. This act shall take effect on the ninetieth day after it shall have become a law.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.